ACST Insider Trading Activity and SEC Form 4 Filings
ACST insider trading summary
No open-market insider purchases or sales of Acasti Pharma Inc. (ACST) have been reported on SEC Form 4 in the past 12 months.
Latest ACST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 25, 2023 | Vimal Kavuru | Director | Buy | $1.2M (676,371 @ $1.85) |
| Aug 31, 2023 | Donald Olds | Director | Buy | $781 (381 @ $2.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.